Related Experiment Video

Updated: Jun 20, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Drug therapies in bronchopulmonary dysplasia: debunking the myths

Win Tin1, Thomas E Wiswell

  • 1James Cook University Hospital, Marton Road, Middlesbrough, UK.

Seminars in Fetal & Neonatal Medicine
|September 15, 2009
PubMed

Insights

Bronchopulmonary dysplasia (BPD), a lung complication in premature infants, is increasing. This review examines evolving definitions and evidence for drug therapies used to prevent or treat BPD.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Perinatal Medicine

Background:

  • Bronchopulmonary dysplasia (BPD), or chronic lung disease (CLD), is a significant complication in premature infants.
  • BPD incidence and characteristics have evolved alongside improved survival rates in premature infants.
  • The definition and management of BPD have changed considerably since its initial description.

Purpose of the Study:

  • To discuss the importance of objective definitions for BPD.
  • To review the evidence supporting drug therapies used in BPD management.
  • To differentiate evidence-based therapies from those based on institutional practices or beliefs.

Main Methods:

  • Literature review of BPD definitions and drug therapies.
  • Analysis of current clinical practices and supporting evidence.
  • Discussion of evolving diagnostic criteria and therapeutic interventions.

Main Results:

  • BPD definitions have evolved to better classify the condition.
  • Evidence varies significantly for different drug therapies used in BPD.
  • Some therapies are routinely supported by evidence, while others lack robust data.

Conclusions:

  • Objective BPD definitions are crucial for consistent diagnosis and research.
  • Critical evaluation of drug therapies is needed to guide clinical practice.
  • Further research is required to establish evidence-based guidelines for BPD treatment.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation